Login / Signup

Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer.

A Borrero-PalaciosA CebriánM T Gómez Del PulgarR García-CarboneroP Garcia-AlfonsoE ArandaE ElezR López-LópezAndres CervantesM ValladaresC NadalJ M ViéitezCarmen Guillén-PonceJ RodríguezI HernándezJ L GarcíaR Vega-BravoA Puime-OtinJ Martínez-UserosL Del Puerto-NevadoR RincónM Rodríguez-RemírezF RojoJ García-Foncillas
Published in: Scientific reports (2019)
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.
Keyphrases
  • metastatic colorectal cancer
  • wild type
  • systematic review
  • randomized controlled trial